AstraZeneca’s anti-diabetic drug gets nod for kidney disease in India
Bengaluru, Feb 8 (SocialNews.XYZ) Pharmaceutical company AstraZeneca India on Monday announced that it has received marketing authorisation for its anti-diabetic drug — dapagliflozin — in India for the treatment of patients of chronic kidney disease…
















